Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

Recent Findings in the Regulation of Programmed Death Ligand 1 Expression

With the recent approvals for the application of monoclonal antibodies that target the well-characterized immune checkpoints, immune therapy shows great potential against both solid and hematologic tumors. The use of these therapeutic monoclonal antibodies elicits inspiring clinical results with dur...

Full description

Bibliographic Details
Main Authors: Xiangfeng Shen, Lihong Zhang, Jicheng Li, Yulin Li, Yishu Wang, Zhi-Xiang Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-06-01
Series:Frontiers in Immunology
Subjects:
PD-L1 expression
intrinsic signals
extrinsic signals
anti-PD-1/PD-L1
immune checkpoint therapy
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01337/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.01337/full

Similar Items